CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0745
-0.0045 (-5.70%)
Apr 28, 2026, 9:30 AM EST

CTTH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2014 FY 2014 2013 - 2011
Period Ending
Dec '25 Dec '24 Dec '23 Dec '14 Feb '14 2013 - 2011
Selling, General & Admin
0.120.240.040.660.01
Upgrade
Amortization of Goodwill & Intangibles
0.010.01---
Upgrade
Operating Expenses
0.130.250.040.660.01
Upgrade
Operating Income
-0.13-0.25-0.04-0.66-0.01
Upgrade
Interest Expense
-0----
Upgrade
Other Non Operating Income (Expenses)
-0.03---0.01-0
Upgrade
Pretax Income
-0.16-0.25-0.04-0.67-0.02
Upgrade
Net Income
-0.16-0.25-0.04-0.67-0.02
Upgrade
Net Income to Common
-0.16-0.25-0.04-0.67-0.02
Upgrade
Shares Outstanding (Basic)
585251160
Upgrade
Shares Outstanding (Diluted)
585251160
Upgrade
Shares Change (YoY)
9.92%3.65%209.26%6435.55%-98.32%
Upgrade
EPS (Basic)
-0.00-0.00-0.00-0.04-0.07
Upgrade
EPS (Diluted)
-0.00-0.00-0.00-0.04-0.07
Upgrade
EBITDA
-0.12-0.24-0.04--
Upgrade
D&A For EBITDA
0.010.010.01--
Upgrade
EBIT
-0.13-0.25-0.04-0.66-0.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.